Endoscopic Mucosal Resection and Cellular Matrix

Barrett Adenocarcinoma Clinical Trial

Official title:
A Randomized Study of Biologic Scaffolds And Esophageal Healing Following Endoscopic Resection

Status Terminated

Clinical Trial Summary

This study is being done to test the usefulness of extracellular matrix (ECM) a thin sheet placed over the site after endoscopic mucosal resection to promote healing of the esophagus.

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Barrett Adenocarcinoma
Barrett Esophagus
Barretts Esophagus With High Grade Dysplasia

Clinical Trial Details

NCT number	NCT03240679
Study type	Interventional
Source	Mayo Clinic
Contact
Status	Terminated
Phase	N/A
Start date	March 22, 2017
Completion date	June 20, 2017

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT01618643` - Aceto-whitening in the Assessment of Gastrointestinal Neoplasia	N/A
Completed	`NCT05628441` - Real-time Computer Aided Detection of Barrett's Neoplasia
Recruiting	`NCT05690958` - Public's Intended Uptake and Views on Organization of Esophageal Cancer Screening
Recruiting	`NCT03427346` - Neoplastic Barrett Esophagus: Endoscopic Piecemeal vs. En Bloc Resection	N/A
Completed	`NCT01871636` - ESD Versus EMR for Treatment of Early Barrett`s Adenocarcinoma	N/A
Not yet recruiting	`NCT05276791` - EMR Versus ESD for Barrett's Neoplasia	N/A
Completed	`NCT06381583` - A Liquid Biopsy for High-risk Pre-cancer Screening of Esophageal Adenocarcinoma